| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
Although infectious, inflammatory and neoplastic diseases frequently involve the pleural space and walls, little is known about the immunological and molecular mechanisms underlying pleural disorders. This article provides an overview of recent insights into immunobiological processes likely to play a role in the pathogenesis of pleural disorders. Pleural involvement in certain diseases is associated with the infiltration of a number of different types of immune cells, such as neutrophils, eosinophils or lymphocytes, in various proportions depending on both the course and the aetiology of the underlying disease. In addition to infiltrating cells, mesothelial cells have been demonstrated to actively participate in pleural inflammation via release of various mediators and proteins, including platelet-derived growth factor (PDGF), interleukin-8, monocyte chemotactic peptide (MCP-1), nitric oxide (NO), collagen, antioxidant enzymes and the plasminogen activation inhibitor (PAI). Furthermore, several inflammatory mediators have been detected at increased concentrations within pleural effusions, including lipid mediators, cytokines and proteins (adenosine deaminase, lysosyme, eosinophil-derived cationic proteins, and products of the coagulation cascade). The presence of these mediators underline the concept of pleural inflammation, and certain cytokines seem to characterize a specific aetiology of pleurisy. The understanding of these processes and the sequence of events leading to pleural loculation, pleural adhesion or repair are likely to provide the basis for early therapeutic intervention and reduce pleural-associated morbidity.
This article has been cited by other articles:
|
|
 |
|
  M. C. Souza, C. Penido, M. F. S. Costa, and M. G. Henriques Mechanisms of T-Lymphocyte Accumulation during Experimental Pleural Infection Induced by Mycobacterium bovis BCG Infect. Immun., December 1, 2008; 76(12): 5686 - 5693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Steger, U. Mika, H. Toomes, T. Walker, C. Engel, T. Kyriss, G. Ziemer, and G. Friedel Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses Ann. Thorac. Surg., June 1, 2007; 83(6): 1940 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Quintana, C. Cannet, E. Schaeublin, S. Zurbruegg, R. Sugar, L. Mazzoni, C. P. Page, J. R. Fozard, and N. Beckmann Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L651 - L657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-M. Tschopp, R. Rami-Porta, M. Noppen, and P. Astoul Management of spontaneous pneumothorax: state of the art. Eur. Respir. J., September 1, 2006; 28(3): 637 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jammes and S. Delpierre Respiratory and circulatory effects of parietal pleural afferent stimulation in rabbits J Appl Physiol, May 1, 2006; 100(5): 1539 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Avila, A. J. Dwyer, A. Rabel, R. M. DeCastro, and J. Moss CT of Pleural Abnormalities in Lymphangioleiomyomatosis and Comparison of Pleural Findings After Different Types of Pleurodesis. Am. J. Roentgenol., April 1, 2006; 186(4): 1007 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Cailhier, D. A. Sawatzky, T. Kipari, K. Houlberg, D. Walbaum, S. Watson, R. A. Lang, S. Clay, D. Kluth, J. Savill, et al. Resident Pleural Macrophages Are Key Orchestrators of Neutrophil Recruitment in Pleural Inflammation Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 540 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits Chest, November 1, 2005; 128(5): 3735 - 3742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Medford and N Maskell Pleural effusion Postgrad. Med. J., November 1, 2005; 81(961): 702 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jammes, D. Trousse, and S. Delpierre Identification and properties of parietal pleural afferents in rabbits J. Physiol., September 1, 2005; 567(2): 641 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X-J. Qin, H-Z. Shi, Z-X. Huang, L-F. Kang, W-N. Mo, and C. Wu Interleukin-16 in tuberculous and malignant pleural effusions Eur. Respir. J., April 1, 2005; 25(4): 605 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kalomenidis, Y. Guo, K. B. Lane, M. Hawthorne, and R. W. Light Transforming Growth Factor-{beta}3 Induces Pleurodesis in Rabbits and Collagen Production of Human Mesothelial Cells Chest, April 1, 2005; 127(4): 1335 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco BTS guidelines for the management of pleural infection in children Thorax, February 1, 2005; 60(suppl_1): i1 - i21. [Full Text] [PDF]
|
|
|
|
 |
|
 T N Hilliard, A J Henderson, and S C L. Hewer Management of parapneumonic effusion and empyema Arch. Dis. Child., October 1, 2003; 88(10): 915 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C W H Davies, F V Gleeson, and R J O Davies BTS guidelines for the management of pleural infection Thorax, May 1, 2003; 58(90002): ii18 - 28. [Full Text]
|
|
|
|
|
|
M. Melis, E. Pace, L. Siena, M. Spatafora, A. Tipa, M. Profita, A. Bonanno, A. M. Vignola, G. Bonsignore, C. H. Mody, et al. Biologically Active Intercellular Adhesion Molecule-1 Is Shed as Dimers by a Regulated Mechanism in the Inflamed Pleural Space Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1131 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.B. Antony Immunological mechanisms in pleural disease Eur. Respir. J., March 1, 2003; 21(3): 539 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zocchi Physiology and pathophysiology of pleural fluid turnover Eur. Respir. J., December 1, 2002; 20(6): 1545 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Silva, E. F. de Assis, L. F. C. Caiado, G. K. Marathe, M. T. Bozza, T. M. McIntyre, G. A. Zimmerman, S. M. Prescott, P. T. Bozza, and H. C. Castro-Faria-Neto Monocyte Chemoattractant Protein-1 and 5-Lipoxygenase Products Recruit Leukocytes in Response to Platelet-Activating Factor-Like Lipids in Oxidized Low-Density Lipoprotein J. Immunol., April 15, 2002; 168(8): 4112 - 4120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A H Thomson, J Hull, M R Kumar, C Wallis, and I M Balfour Lynn Randomised trial of intrapleural urokinase in the treatment of childhood empyema Thorax, April 1, 2002; 57(4): 343 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. King and A. Thomson Radiological perspectives in empyema: Childhood respiratory infections Br. Med. Bull., March 1, 2002; 61(1): 203 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-s. Cheng, Y. C. G. Lee, J. T. Rogers, E. A. Perkett, J. P. Moyers, R. M. Rodriguez, and R. W. Light Vascular Endothelial Growth Factor Level Correlates With Transforming Growth Factor-{beta} Isoform Levels in Pleural Effusions Chest, December 1, 2000; 118(6): 1747 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bouros, M. Froudarakis, and N. M. Siafakas Pleurodesis : Everything Flows Chest, September 1, 2000; 118(3): 577 - 579. [Full Text] [PDF]
|
|
|
|
|
|
E. PACE, M. GJOMARKAJ, M. MELIS, M. PROFITA, M. SPATAFORA, A. M. VIGNOLA, G. BONSIGNORE, and C. H. MODY Interleukin-8 Induces Lymphocyte Chemotaxis into the Pleural Space . Role of Pleural Macrophages Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1592 - 1599. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
